Author’s Note: This piece was catalyzed by themes explored at ReImagine Pharma Marketing 2026 and develops them into an independent perspective on the emerging crossover among obesity treatment, beauty, personal care, and consumer health.
The first phase of the modern obesity market focused on legitimacy: establishing obesity as a chronic disease, moving the conversation beyond willpower, engaging healthcare providers and payers, and demonstrating clinically meaningful weight loss.
The next phase will likely focus on more specific needs. Weight loss will still matter, but so will keeping it off, side effects, muscle health, energy, other health issues, how the medicine is taken and quality of life. Novel mechanisms and delivery formats may help meet these needs. [McKinsey]
This evolution raises a question: What happens when treatment success expands from weight loss to how well a person feels and functions throughout the experience, and what market does that create?
Beauty and personal care may be part of the answer.
As obesity treatment broadens from weight loss to whole-person outcomes, a consumer-facing layer could emerge around the physical, emotional and aesthetic dimensions of transformation. This would create demand across skin, scalp, hair, body care, nutrition, aesthetics, movement, fragrance, cosmetics and self-expression.
The Obesity Market Is Becoming More Segmented
People often judge the obesity market by how well its top medicines work. But the patient journey reveals a more heterogeneous landscape.
Some patients respond quickly; others progress gradually. Some reach a plateau, move into maintenance, switch therapies, pause treatment or return later. Others need tailored approaches based on age, sex, life stage, comorbidities, treatment history, body composition, or preserving strength and energy.
Persistence is revealing. When patients discontinue, restart, switch or cycle through therapies, they show distinct stages of need. A patient seeking significant initial weight loss may require a different care framework than one focused on maintenance. A younger consumer may have expectations distinct from a postmenopausal woman experiencing metabolic and hormonal changes. Someone prioritizing strength and muscle preservation may experience treatment differently from someone managing diabetes, cardiovascular risk, or another comorbidity. [McKinsey] · [Kline]
There isn’t just one type of GLP-1 user.
This heterogeneity extends beyond medicine. It creates room for an adjacent care ecosystem.
Consumers Are Already Building Their Own Ecosystems
GLP-1 use has moved rapidly into the mainstream. National polling in July 2026 found that 11% of U.S. adults were taking a GLP-1 medication for weight loss, up from 3% in 2024. Fifteen percent had used one at some point. [Gallup]
A 2026 study found 80% of users relied on at least one extra product, and over half had been on treatment for more than a year. People are assembling routines across nutrition, supplements, exercise, clothing, and wellness products. [PwC]
Consumer data show GLP-1 users consider beauty and personal-care brands more than the broader population, with clear variation by age and income. Younger users show greater interest in expressive cosmetics, fitness and identity-led brands. Older consumers prefer skin health and functional care, while higher-income users prefer prestige beauty. [Morning Consult]
This pattern of self-investment goes beyond corrective care. A changed silhouette may prompt wardrobe reinvention. Greater physical activity may reshape body care routines. A recalibrated relationship with appearance may inspire experimentation with skin care, cosmetics, fragrance or personal style.
In one study, 52% of current GLP-1 users felt more positive about their appearance, and 43% felt motivated to take better care of it. Respondents showed interest in facial skin care for dryness, sensitivity and elasticity; body care for hydration and firmness; and hair care for thinning and texture. [Acosta Group]
Separate global research conducted by Merz Aesthetics in partnership with Ipsos found that 73% of respondents felt “empowered” after having an aesthetic treatment. The study surveyed 15,000 adults across 15 countries who had undergone an aesthetic treatment or were open to one. [Merz Aesthetics/Ipsos]
Transformation as an Emerging Segmentation Model
Beauty has traditionally been understood in terms of age, skin type, product category or individual concern. The GLP-1 journey introduces another organizing principle: the stage of transformation.
At the start of treatment, consumers may prioritize hydration, skin comfort, scalp care and routines that fit their changing daily habits. During active weight loss, facial and body skin, hair quality, muscle tone, nutrition, and energy may become more important. As weight stabilizes, priorities may shift to long-term skin quality, hair density, body care, cosmetics, aesthetic services and personal style. [McKinsey] · [Kline]
Maintenance introduces a consumer state focused on resilience, consistency and long-term strength. Pausing, switching or returning to treatment may create moments when routines need to adapt.
These stages could guide product development, services and personalized experiences. Transformation care would focus on how needs evolve and connect over time.
Skin Quality and Resilience
Substantial weight loss can alter facial volume and accentuate differences in elasticity, hydration, texture and firmness. Research has documented redistribution of facial fat and skin laxity. Aesthetic Surgery Journal
This creates opportunities for skin care that supports skin quality and resilience. Ingredients like hyaluronic acid and glycerin help with hydration. Ceramides, emollients and occlusives protect the skin barrier. Retinoids can improve fine lines and aging, while peptides, antioxidants and advanced delivery systems may boost smoothness, glow and firmness.
A key innovation question is how these familiar technologies can be reformulated, sequenced and personalized across successive stages of physical adaptation.
Hair and Scalp Health
Hair care represents another intersection between beauty and clinical oversight. Hair shedding has been reported during GLP-1-associated weight reduction, while research continues to investigate the relative roles of rapid physiological adaptation, nutritional intake, hormones and the hair growth cycle. FDA prescribing information
Dermatologists identify telogen effluvium as a possible explanation for shedding after substantial or rapid weight loss, making accurate identification of the underlying hair condition important. American Academy of Dermatology
A crossover model could link cosmetic care with professional guidance: gentler cleansing, scalp-support products, breakage care, volumizing formats, density regimens, nutritional evaluation and access to dermatologic expertise.
The Body as an Interconnected System
Body care could advance as people pay attention to hydration, texture, firmness, strength, movement and how their bodies feel during weight reduction.
This creates opportunities for richer moisturization, concentrated body serums, massage formats, products promoting a smoother appearance, and services complementing movement and strength training.
Body composition adds another dimension. Research shows that weight reduction can involve reductions in both fat and lean mass, increasing attention to protein intake, physical function, resistance training and muscle preservation. SURMOUNT-1 body-composition substudy, semaglutide lean-mass review
The goal is more than looking different; it is about feeling strong, healthy and supported.
Early Models of Transformation Care
Early activity in professional skin care suggests that transformation care is beginning to take several forms.
One model reorganizes an existing portfolio around the GLP-1 journey. ALASTIN’s transformation collection connects facial skin care, neck care, body care and products used with aesthetic procedures. The significance lies less in any individual formula than in presenting these needs as one connected regimen. ALASTIN
A second model adds a GLP-1-specific evidence layer to established skin technologies. SkinCeuticals has tested its A.G.E. regimen with GLP-1 patients and positioned it alongside professional tightening procedures. This begins to establish a population-specific evidentiary standard: products organized around a treatment population and evaluated within that population. SkinCeuticals
A third model is purpose-built innovation. Products such as Image Skincare’s VOL.U.LIFT and Dr. Few’s DermaReverse have been developed around the visible facial changes associated with substantial weight loss. Market overview
Together, these approaches suggest three entry points into the whitespace: curated regimens, population-specific substantiation and purpose-built products. They also show how beauty may connect topical care with aesthetic medicine, while pharmaceutical and consumer-health companies explore the supportive experience around treatment.
Metabolic Beauty as an Emerging Category Logic
Metabolic beauty may become more than a product opportunity.
Several signals are converging: growing conversation around GLP-1-related skin and hair changes; rising interest in skin longevity and sensorial wellness; increased personal-care spending among GLP-1 households; and the emergence of complementary nutrition products focused on satiety, protein, hydration and muscle preservation. Even after treatment pauses, personal-care purchasing remains elevated, suggesting some routines may outlast medication use. [Mintel + Black Swan Data] · [Mintel] · [WGSN] · [Stylus] · [The Future Laboratory] · [PwC]
The opportunity may also extend beyond current users. Alongside pharmaceutical adoption is a wellness-first consumer interested in metabolic health, appetite regulation, strength and longevity through nonprescription pathways. These are parallel expressions of the same broader convergence: consumers increasingly experience internal health and external appearance as a single, interconnected system.
GLP-1 households are estimated to spend approximately 30% more on beauty than non-user households, indicating that this convergence is already evident. [Circana]
The Front Door Is Becoming a Shared Space
Access pathways into obesity treatment are increasing. A patient may begin through primary care, a specialist, a pharmacy, a telehealth platform, a direct-to-patient service, a medspa or another consumer health channel. [PwC]
At the same time, beauty brands are extending into clinical science, diagnostics, longevity and professional services. Pharma and healthcare companies are developing more consumer-facing capabilities, and telehealth platforms are integrating treatment with nutrition, coaching, hair care, skin care and wellness. [McKinsey] · [Kline]
This is creating a shared space between medical prescriptions and the beauty counter.
For pharmaceutical companies, that space may address the lived experience around treatment while building consumer understanding and persistence. For beauty companies, it may offer access to newly legible needs grounded in metabolic and physiological adaptation. Retailers, pharmacies, telehealth platforms, dermatologists, nutrition professionals and aesthetic providers could connect the two.
Early signs of this trend may already be seen in treatment-support materials, where dermatologist-trusted skin care brands show up through professional recommendations, samples or patient offers. These touchpoints suggest that supportive beauty care could become part of the broader treatment experience, especially when products are selected for their tolerability and supported by relevant evidence.
From Efficacy to the Whole Person
The next phase may ask a bigger question: What does it mean to help someone feel healthy, strong, comfortable, confident and supported over time?
The GLP-1 consumer is asking the broader care ecosystem for something simple: treat all of me.The opportunity is to imagine what whole-person care could be when pharmaceutical advances and beauty expertise come together.
Jeannie Joshi is a global brand strategy and creative executive, design educator, and innovation leader whose work integrates branding, creativity, and culture. She applies semiotics and ethnography to brand innovation and advances generative AI literacy and governance for enterprises and learners.
